SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?

José Antonio Bengoechea Connor G G Bamford

Published in: EMBO molecular medicine (2020)

Respiratory viral infections are well known to predispose patients to bacterial co-infections and superinfections. Still, there is limited reference to these in COVID-19. Do co-infections play a significant role during COVID-19? What is the impact of antimicrobial resistance?

Keyphrases

sars cov
antimicrobial resistance
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
patient reported